{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/patient-recruitment-clinical-operations-nash-trials#webpage",
"url": "https://www.fortrea.com/insights/patient-recruitment-clinical-operations-nash-trials",
"name": "Accelerating Patient Recruitment and Clinical Operations in NASH Clinical Trials",
"description": "This Fortrea case study highlights the lessons learned from 14 NASH clinical trials conducted over four years and demonstrates how data-driven recruitment and operational strategies can improve trial efficiency in a challenging clinical landscape. NASH studies often face significant obstacles, including high screen failure rates, limited availability of experienced investigators, nonperforming sites, and patient reluctance to undergo liver biopsies as part of enrollment requirements. By analyzing real-world screening, recruitment, and dropout data from more than 2,000 randomized patients, Fortrea developed enhanced screening paradigms with defined cutoff values and site support tools that helped reduce screen failure rates from approximately 80% to as low as 30% at some sites while routinely achieving averages around 55%. The organization also leveraged extensive NAFLD/NASH site performance data to identify high-performing investigators, improve site selection, reduce unnecessary liver biopsies, enhance site motivation, and support more efficient patient recruitment and study execution. These insights enabled sponsors to optimize enrollment strategies, improve operational performance, and advance NASH clinical development programs with greater confidence and efficiency."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Accelerating Patient Recruitment and Clinical Operations in NASH Clinical Trials",
"item": "https://www.fortrea.com/insights/patient-recruitment-clinical-operations-nash-trials"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/patient-recruitment-clinical-operations-nash-trials#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/patient-recruitment-clinical-operations-nash-trials#webpage"
},
"headline": "NASH Clinical Trial Patient Recruitment: Reducing Screen Failure Rates and Improving Site Performance | Fortrea Case Study",
"description": "This Fortrea case study highlights the lessons learned from 14 NASH clinical trials conducted over four years and demonstrates how data-driven recruitment and operational strategies can improve trial efficiency in a challenging clinical landscape. NASH studies often face significant obstacles, including high screen failure rates, limited availability of experienced investigators, nonperforming sites, and patient reluctance to undergo liver biopsies as part of enrollment requirements. By analyzing real-world screening, recruitment, and dropout data from more than 2,000 randomized patients, Fortrea developed enhanced screening paradigms with defined cutoff values and site support tools that helped reduce screen failure rates from approximately 80% to as low as 30% at some sites while routinely achieving averages around 55%. The organization also leveraged extensive NAFLD/NASH site performance data to identify high-performing investigators, improve site selection, reduce unnecessary liver biopsies, enhance site motivation, and support more efficient patient recruitment and study execution. These insights enabled sponsors to optimize enrollment strategies, improve operational performance, and advance NASH clinical development programs with greater confidence and efficiency.",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2024-10-15",
"dateModified": "2024-10-15",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2024-10/CS%200008%20Insight%20NASH%20Studies%200723.pdf",
"encodingFormat": "application/pdf"
}
}
]
}